Hematología y Hemoterapia

Resultados: 392
Tipo Título / Nombre Autor(es) Año
Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real-world setting Alegre A, Gironella M, Escalante F, Bergua JM, Martínez-Chamorro C, López A, et al 2024
Data-driven flow cytometry classification of blast differentiation in elderly patients with acute myeloid leukemia Simoes C, González C, Vergez F..., Bergua JM 2024
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry Labrador J, Martínez-Cuadrón D, Boluda B, Serrano J, Gil C..., Bergua JM, et al 2024
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice González-López TJ, Bermejo N, Cardesa-Cabrera R, Martínez V, Aguilar-Monserrate G, Pérez Segura G, et al 2024
Targeting CD38 by isatuximab and a CD38/CD3xCD28 trispecific T-cell engager in old patients with acute myeloid leukemia Martin-Sánchez E, Blanco Fernández L, Kim PS, Bisht K, Wang H..., Bergua Burgues JM, et al 2024
Validation of mutated CEBPA bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registry De la Torre EP, Serrano J, Martínez-Cuadrón D, Torres L, Sargas C..., Bergua JM, et al 2024
CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDPGOTEL trial in recurrent/ refractory diffuse large B cell lymphoma Hontecillas-Prieto L, García-Domínguez DJ, Palazón-Carrión N, Martín García-Sancho A..., Carnicero González F 2024
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC Gresele P, Falcinelli E, Bury L, Alessi MC, Guglielmini G..., Bermejo N, et al 2024
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial Ribera JM, Morgades M, Garcia-Calduch O, Sirvent M, Buendia B..., Bergua JM, et al 2024
Outcomes after intensive chemotherapy for secondary and myeloidrelated changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry Martínez-Cuadrón D, Megías-Vericat JE, Gil C, Bernal T, Tormo M..., Bergua J, et al 2024